Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02231164
Title LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Indications

lung adenocarcinoma

Therapies

Docetaxel

Nintedanib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST